
Studies into the molecular mechanisms of cancer have revealed that, with a few exceptions, the disease lacks a specific drug zzso zzso new zzso drugs not only take many years and much money to develop but also might not outperform existing zzso However, what are assumed to be zzso hallmarks of cancer, for example drug resistance, can be exploited for selective zzso therapy and for protection of normal zzso Based on this zzso the drug discovery can be zzso by novel use of existing agents and even zzso zzso The pharmacological industry could develop low cost, effective therapeutic zzso by zzso already marketed and late-stage products in zzso therapeutic zzso 

